This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2013 by Mary Larimer, University of Washington.
Recruitment status was:  Enrolling by invitation
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Mary Larimer, University of Washington
ClinicalTrials.gov Identifier:
NCT01529047
First received: February 3, 2012
Last updated: December 10, 2013
Last verified: December 2013
  Purpose
Rates of gambling and substance use behaviors are elevated among emerging adults (ages 18-24), and these behaviors are individually and jointly associated with a host of negative consequences. Evidence suggests there is significant overlap between these behaviors as well as comorbidity of associated mental disorders (i.e., pathological gambling and substance abuse/dependence). Prior research suggests that a brief in-person delivered personalized feedback intervention (PFI) may be an effective method of reducing these behaviors and their associated consequences among emerging adults. Thus, the purpose of this study is to determine the relative efficacy of an in-person delivered PFI versus a Web-based PFI in reducing gambling, alcohol and marijuana use behaviors and related-consequences in a sample of emerging adults, as well as explore potential moderators and mediators of intervention efficacy and the longevity of intervention effects (over a period of 18-months).

Condition Intervention Phase
Gambling Alcohol Consumption Cannabis Behavioral: Personalized Feedback Intervention Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: RTC of Web Versus In-Person SUD and Comorbidity Treatment

Resource links provided by NLM:


Further study details as provided by Mary Larimer, University of Washington:

Primary Outcome Measures:
  • gambling behavior and consequences [ Time Frame: across 18 months ]

Estimated Enrollment: 375
Study Start Date: February 2010
Estimated Study Completion Date: January 2015
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: In-person PFI
In-person personalized feedback intervention
Behavioral: Personalized Feedback Intervention
Printed or electronic form containing personalized information about health-relevant behaviors
Experimental: Web-based PFI
Web-based personalized feedback intervention
Behavioral: Personalized Feedback Intervention
Printed or electronic form containing personalized information about health-relevant behaviors
No Intervention: Assessment Only
Complete online survey assessments only.

  Eligibility

Ages Eligible for Study:   17 Years to 24 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Endorse disordered gambling behavior (including 1 or more consequence)
  • Meet diagnostic criteria for one or more substance use disorder

Exclusion Criteria:

  • Not meeting inclusion criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01529047

Locations
United States, Washington
University of Washington
Seattle, Washington, United States, 98195
Sponsors and Collaborators
University of Washington
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Mary E Larimer, Ph.D. University of Washington Dept of Psychiatry & Behavioral Sciences
  More Information

Responsible Party: Mary Larimer, Professor, University of Washington
ClinicalTrials.gov Identifier: NCT01529047     History of Changes
Other Study ID Numbers: 35898-C
R01DA025051 ( US NIH Grant/Contract Award Number )
Study First Received: February 3, 2012
Last Updated: December 10, 2013

Additional relevant MeSH terms:
Gambling
Alcohol Drinking
Disruptive, Impulse Control, and Conduct Disorders
Mental Disorders
Drinking Behavior

ClinicalTrials.gov processed this record on June 23, 2017